Lynch-like Syndrome is As Frequent As Lynch Syndrome in Early-onset Nonfamilial Nonpolyposis Colorectal Cancer
Overview
Authors
Affiliations
Early-onset (<50 years-old) nonpolyposis nonfamilial colorectal cancer (EO NP NF CRC) is a common clinical challenge. Although Lynch syndrome (LS) is associated with EO CRC, the frequency of this syndrome in the EO NF cases remains unknown. Besides, mismatch repair deficient (MMRd) CRCs with negative MMR gene testing have recently been described in up to 60% of cases and termed "Lynch-like syndrome" (LLS). Management and counseling decisions of these patients are complicated because of unconfirmed suspicions of hereditary cancer. To define the prevalence of MMR deficient CRCs, LS and LLS in patients with EO NP NF CRC, we recruited 102 patients with a first diagnosis of NP NF CRC ≤ 50 years old during 2003-2009 who underwent genetic counseling at our institution in Argentina. Tumor immunohistochemical (IHC) MMR for protein expression and microsatellite instability (MSI) status were evaluated, and in those with loss of MLH1 expression by IHC, somatic BRAF V600E mutation and both somatic and germline MLH1 methylation levels were studied. Tumors characterized as MMRd without somatic BRAF mutation nor MLH1 methylation were sent for germline analysis. Twenty one (20.6%) tumors were MMRd. Fourteen of 16 putative LS cases underwent germline testing: 6 pathogenic mutations were identified and 8 cases had no identifiable pathogenic mutations. The prevalence of LS and LLS in this cohort was 5.8% (6/102) and 7.8% (8/102), respectively. As a conclusion we found that 20% of patients with EO NP NF CRC have MMRd tumors, and at least half of these are likely to have LLS.
Hamilton A, Bannon F, Dunne P, James J, McQuaid S, Gray R Gastro Hep Adv. 2024; 2(3):347-359.
PMID: 39132649 PMC: 11307521. DOI: 10.1016/j.gastha.2022.11.005.
Clinicopathological characteristics of Lynch-like syndrome.
Nakamori S, Takao M, Takao A, Natsume S, Iijima T, Kojika E Int J Clin Oncol. 2024; 29(7):944-952.
PMID: 38642190 DOI: 10.1007/s10147-024-02527-x.
Screening and surveillance for hereditary colorectal cancer.
Kim H, Kim T Intest Res. 2024; 22(2):119-130.
PMID: 38311713 PMC: 11079514. DOI: 10.5217/ir.2023.00112.
Pantaleo A, Forte G, Cariola F, Valentini A, Fasano C, Sanese P Cancers (Basel). 2023; 15(20).
PMID: 37894428 PMC: 10605602. DOI: 10.3390/cancers15205061.
Molecular functions of MCM8 and MCM9 and their associated pathologies.
Helderman N, Terlouw D, Bonjoch L, Golubicki M, Antelo M, Morreau H iScience. 2023; 26(6):106737.
PMID: 37378315 PMC: 10291252. DOI: 10.1016/j.isci.2023.106737.